Health4Men News

A new $7 million grant for the Anova Health Institute’s Health4Men project to address HIV in South Africa’s gay, bisexual and MSM (men who have sex with men) community has been announced in both Washington and Johannesburg. This significant international funding boost to expand MSM-targeted HIV-related services in South Africa is the result of a new partnership between the Elton John AIDS Foundation and the US President’s Emergency Plan for AIDS Relief (PEPFAR).

On October 10, the U.S. Food and Drug Administration (FDA) approved a new once-daily combination pill for the treatment of genotype 1 chronic hepatitis C containing Gilead Sciences’ HCV nucleotide polymerase inhibitor sofosbuvir (Sovaldi) plus ledipasvir, the first approved HCV NS5A inhibitor.

Use of prescription erectile dysfunction (ED) medication was significantly associated with sexual risk behavior in HIV-positive men, according to data presented at IDWeek 2014 by Greer Burkholder, MD, of the Infectious Diseases Department, University of Alabama at Birmingham.

To help address the HIV epidemic among young members of key populations, the United Nations Interagency Working Group on Key Populations has produced a series of technical briefs focused on the needs and realities of young men who have sex with men, young people who sell sex, young people who use drugs, and young transgender people.

Two new studies indicate differences in treatment among racial groups.

HIV drugs which only need to be taken once a month are to be developed at the University of Liverpool in a bid to overcome the problem of ‘pill fatigue’.

Using patients’ genetic material to help attack their particular version of HIV.